Department of Oral Medicine and Periodontology, Faculty of Dentistry, Mahidol University, 6 Yodhi Str,, Rajthewee, Bangkok 10400, Thailand.
Diabetol Metab Syndr. 2014 Feb 14;6(1):19. doi: 10.1186/1758-5996-6-19.
The relationship of saliva with plasma protein levels makes saliva an attractive diagnostic tool. Plasma levels of adiponectin and leptin in healthy individuals or diabetes mellitus patients have been previously reported. Nevertheless, salivary levels of these adipocytokines in patients with metabolic syndrome (MS) have never been investigated. This study was aimed to determine adiponectin and leptin levels in saliva and plasma from patients with metabolic syndrome, and evaluate any correlation of these levels with MS.
Forty-six healthy and 82 MS patients were enrolled. Demographic data and blood biochemistries were recorded. Saliva and plasma adiponectin and leptin levels were analyzed by enzyme-linked immunosorbent assay (ELISA).
Adiponectin and leptin were higher in plasma than in saliva (p < .001). Plasma adiponectin was decreased and plasma leptin increased in patients with MS (p < .001). Salivary adiponectin and salivary leptin were not different between healthy subjects and MS patients (p = .619 and p = .523). Correlation between salivary and plasma adiponectin showed significant association (r = .211, p = .018) while salivary and plasma leptin had no correlation (r = -.161, p = .069). Significant correlation was observed between the salivary adiponectin/salivary leptin ratio and plasma adiponectin (r = .371, p < .001), but not with any component of MS. Increased triglyceride and waist circumference were associated with risk of having a low level of plasma adiponectin (OR = 1.009; 95% CI 1.002-1.015 and OR = 1.125; 95% CI 1.029-1.230). For leptin, body mass index and high-density lipoprotein cholesterol (HDL-C) were associated with a high level of plasma leptin (OR = 1.621; 95% CI 1.212-2.168 and OR = .966; 95% CI .938-.996). The OR for MS as predicted by plasma adiponectin was .928 (95% CI .881-.977).
This study showed that salivary adiponectin and leptin do not correlate with MS. Although correlation between salivary and plasma adiponectin was observed, no association with MS was observed. Only plasma adiponectin may be useful for the prediction of MS.
唾液与血浆蛋白水平的关系使唾液成为一种有吸引力的诊断工具。健康个体或糖尿病患者的血浆脂联素和瘦素水平此前已有报道。然而,代谢综合征(MS)患者的唾液中这些脂肪细胞因子的水平从未被研究过。本研究旨在确定代谢综合征患者唾液和血浆中的脂联素和瘦素水平,并评估这些水平与 MS 的任何相关性。
纳入 46 名健康者和 82 名 MS 患者。记录人口统计学数据和血液生化指标。通过酶联免疫吸附试验(ELISA)分析唾液和血浆中的脂联素和瘦素水平。
脂联素和瘦素在血浆中的水平高于唾液(p<0.001)。MS 患者的血浆脂联素降低,血浆瘦素增加(p<0.001)。健康受试者和 MS 患者的唾液脂联素和唾液瘦素无差异(p=0.619 和 p=0.523)。唾液和血浆脂联素之间的相关性显示出显著的相关性(r=0.211,p=0.018),而唾液和血浆瘦素之间没有相关性(r=-0.161,p=0.069)。唾液脂联素/唾液瘦素比值与血浆脂联素呈显著相关(r=0.371,p<0.001),但与 MS 的任何成分均无相关性。甘油三酯和腰围增加与血浆脂联素水平降低的风险相关(OR=1.009;95%CI 1.002-1.015 和 OR=1.125;95%CI 1.029-1.230)。对于瘦素,体重指数和高密度脂蛋白胆固醇(HDL-C)与血浆瘦素水平升高相关(OR=1.621;95%CI 1.212-2.168 和 OR=0.966;95%CI 0.938-0.996)。血浆脂联素预测 MS 的 OR 为 0.928(95%CI 0.881-0.977)。
本研究表明,唾液脂联素和瘦素与 MS 不相关。尽管观察到唾液和血浆脂联素之间存在相关性,但与 MS 无关。只有血浆脂联素可能对 MS 的预测有用。